IRIS
BIANCHI, MARZIA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 10.980
EU - Europa 6.359
AS - Asia 3.888
SA - Sud America 328
AF - Africa 64
OC - Oceania 27
Continente sconosciuto - Info sul continente non disponibili 7
Totale 21.653
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 10.818
GB - Regno Unito 2.394
CN - Cina 1.862
SG - Singapore 1.063
UA - Ucraina 826
IT - Italia 810
SE - Svezia 486
RU - Federazione Russa 434
DE - Germania 404
FI - Finlandia 399
TR - Turchia 340
BR - Brasile 265
VN - Vietnam 195
IE - Irlanda 185
FR - Francia 176
CA - Canada 108
IN - India 104
JP - Giappone 64
KR - Corea 48
PL - Polonia 47
BE - Belgio 44
HK - Hong Kong 44
MX - Messico 43
PK - Pakistan 31
NL - Olanda 29
BD - Bangladesh 27
ES - Italia 27
AR - Argentina 26
ZA - Sudafrica 20
AU - Australia 18
CZ - Repubblica Ceca 18
IQ - Iraq 18
AT - Austria 15
LT - Lituania 15
MA - Marocco 11
RO - Romania 11
IR - Iran 10
VE - Venezuela 10
EG - Egitto 9
ID - Indonesia 9
NZ - Nuova Zelanda 9
SA - Arabia Saudita 9
TG - Togo 9
AE - Emirati Arabi Uniti 8
IL - Israele 7
JO - Giordania 7
CL - Cile 6
EC - Ecuador 5
EU - Europa 5
HU - Ungheria 5
KG - Kirghizistan 5
PT - Portogallo 5
PY - Paraguay 5
SK - Slovacchia (Repubblica Slovacca) 5
BG - Bulgaria 4
CO - Colombia 4
JM - Giamaica 4
NP - Nepal 4
PH - Filippine 4
TW - Taiwan 4
UZ - Uzbekistan 4
AZ - Azerbaigian 3
BH - Bahrain 3
CH - Svizzera 3
CR - Costa Rica 3
DZ - Algeria 3
KE - Kenya 3
KZ - Kazakistan 3
LV - Lettonia 3
NO - Norvegia 3
PE - Perù 3
QA - Qatar 3
TN - Tunisia 3
BO - Bolivia 2
DK - Danimarca 2
GR - Grecia 2
IM - Isola di Man 2
LA - Repubblica Popolare Democratica del Laos 2
MY - Malesia 2
PA - Panama 2
RS - Serbia 2
TH - Thailandia 2
UY - Uruguay 2
A2 - ???statistics.table.value.countryCode.A2??? 1
AM - Armenia 1
CG - Congo 1
CI - Costa d'Avorio 1
CY - Cipro 1
ET - Etiopia 1
GE - Georgia 1
GT - Guatemala 1
LU - Lussemburgo 1
MK - Macedonia 1
MU - Mauritius 1
NG - Nigeria 1
RE - Reunion 1
SI - Slovenia 1
SV - El Salvador 1
XK - ???statistics.table.value.countryCode.XK??? 1
Totale 21.653
Salva come PNG Salva come JPEG
Città #
Southend 2.147
Ashburn 1.276
Woodbridge 1.177
Fairfield 1.141
Houston 751
Ann Arbor 736
Jacksonville 660
Singapore 550
Chandler 506
Seattle 488
San Jose 485
Cambridge 455
Wilmington 393
Nanjing 326
Beijing 296
Dallas 289
Izmir 247
Boardman 222
Helsinki 192
Dublin 183
Los Angeles 140
Urbino 140
Nanchang 130
New York 120
Lauterbourg 98
Munich 98
Princeton 97
San Mateo 94
Council Bluffs 90
Düsseldorf 86
Shenyang 82
Hebei 65
Changsha 64
Tianjin 54
Ho Chi Minh City 52
Bremen 50
Jiaxing 50
Istanbul 49
Santa Clara 49
Buffalo 46
Brussels 43
Hong Kong 41
Frankfurt am Main 40
San Diego 40
Tokyo 40
São Paulo 38
Moscow 37
Shanghai 37
Jinan 36
London 35
Montreal 34
Hanoi 33
Kunming 32
Mülheim 31
San Francisco 31
Toronto 31
Denver 30
Warsaw 29
Chennai 28
Poplar 28
Hangzhou 27
Zhengzhou 27
Guangzhou 26
Orem 26
Seongnam 26
Velikiy Novgorod 26
Turku 25
Dong Ket 24
Ottawa 24
Atlanta 22
Chicago 22
Ningbo 20
Stockholm 20
The Dalles 19
Des Moines 18
Brooklyn 17
Mexico City 16
Bologna 15
Rawalpindi 15
Rome 15
Venice 15
Brno 14
Macerata 14
Mumbai 14
Pesaro 14
Seoul 14
Norwalk 13
Redwood City 13
Agugliano 12
Ascoli Piceno 12
Kraków 12
Lanzhou 12
Ancona 11
Boston 11
Changchun 11
Manchester 11
Taizhou 11
Wuppertal 11
Milan 10
Nuremberg 10
Totale 15.543
Salva come PNG Salva come JPEG
Nome #
Yin Yang 1 intronic binding sequences and splicing elicit intron-mediated enhancement of ubiquitin C gene expression 461
Stochastic modelling of PTEN regulation in brain tumors: a model for Glioblastoma Multiforme 447
Covalent functionalization of SWCNTs with ODNs targeting NF-kB: toward the construction of cell-penetrating decoy molecoles. 389
Molecular Dissection of the Human Ubiquitin C Promoter Reveals Heat Shock Element Architectures with Activating and Repressive Functions 371
Ubiquitin C gene: Structure, function, and transcriptional regulation 344
Dynamic transcription of ubiquitin genes under basal and stressful conditions and new insights into the multiple UBC transcript variants 335
Ubiquitin over-expression promotes E6AP autodegradation and reactivation of the p53/MDM2 pathway in HeLa cells 330
Nano-Mechanical Characterization of Ataxia Telangiectasia Cells Treated with Dexamethasone 319
Label-free quantification of activated NF-kB in biological samples by atomic force microscopy 316
A negative feedback mechanism links UBC gene expression to ubiquitin levels by affecting RNA splicing rather than transcription. 295
A potent enhancer element in the 5'-UTR intron is crucial for transcriptionalregulation of the human ubiquitin C gene 292
A recombinant human 'mini'-hexokinase is catalytically active and regulated by hexose 6-phosphates 289
Transcription factor decoy oligonucleotides modified with locked nucleic acids: an in vitro study to reconcile biostability with binding affinity 287
Dexamethasone improves redox state in ataxia telangiectasia cells by promoting an NRF2-mediated antioxidant response 286
Forward subtractive libraries containing genes transactivated by dexamethasone in ataxia-telangiectasia lymphoblastoid cells 279
Immunophilin-loaded erythrocytes as a new delivery strategy for immunosuppressive drugs 279
A NONLINEAR THREE-COMPARTMENT MODEL FOR THE ADMINISTRATION OF 2’, 3’- DIDEOXYCYTIDINE BY USING RED BLOOD CELLS AS BIOREACTORS 274
Dexamethasone partially rescues ataxia telangiectasia-mutated (ATM) deficiency in ataxia telangiectasia by promoting a shortened protein variant retaining kinase activity. 272
Dehydroascorbic acid irreversibly inhibits hexokinase activity. 269
Locked nucleic acids (LNA): versatile tools for designing oligonucleotide decoys with high stability and affinity 265
De-ubiquitylation is the most critical step in the ubiquitin mediated homeostatic control of the NF-kB/IKK basal activity 265
Expression, purification, and characterization of a recombinant erythroid-specific hexokinase isozyme 263
Oxidized ultrashort nanotubes as carbon scaffolds for the construction of cell-penetrating NF-kappaB decoy molecules 262
Resveratrol fuels HER2 and ERα-positive breast cancer behaving as proteasome inhibitor 256
Comparison of uricase-bound and uricase-loaded erythrocytes as bioreactors for uric acid degradation. 248
Comparison of uricase-bound and uricase-loaded erythrocytes as bioreactors for uric acid degradation 245
Activation of NRF2 by dexamethasone in ataxia telangiectasia cells involves KEAP1 inhibition but not the inhibition of p38 245
Design and characterization of decoy oligonucleotides containing locked nucleic acids 243
The Ubiquitin Gene Expression Pattern and Sensitivity to UBB and UBC Knockdown Differentiate Primary 23132/87 and Metastatic MKN45 Gastric Cancer Cells 236
2',3'- Dideoxycytidine permeation of the human erythrocyte membrane. 235
Drug delivery systems 235
Acetaldehyde dehydrogenase-loaded erythrocytes as bioreactors for the removal of blood acetaldehyde 233
Human red blood cells as bioreactors for the release of 2', 3'-dideoxycytidine, an inhibitor of HIV infectivity. 228
Binding of non-catalytic ATP to human hexokinase I highlights the structural components for enzyme-membrane association control. 227
Efficient inhibition of macrophage TNF-alpha production upon targeted delivery of K48R ubiquitin 226
Identification of blood erythroid markers useful in revealing erythropoietin abuse in athletes 219
High-level expression and purification of a human "mini"-hexokinase 215
Human hexokinase type I microheterogeneity is due to different amino-terminal sequences 212
Cloning and expression of a new human polypeptide which regulates protein phosphorylation in Escherichia coli 212
DOWNREGULATION OF NITRIC OXIDE FORMATION BY CYTOSOLIC PHOSPHOLIPASE A2-RELEASED ARACHIDONIC ACID. 210
Hexokinase 209
Activation of the ubiquitin proteolytic system in murine acquired immunodeficiency syndrome affects IkB-alpha turnover 207
Red Blood Cell Membrane Processing for Biomedical Applications 206
The ubiquitin-dependent proteolytic system and other potential targets for the modulation of nuclear factor-kB (NF-kB) 205
Overexpression of wild-type ubiquitin downregulates transcription of endogenous polyubiquitin genes in HeLa cells 205
Human red blood cells as bioreactors for the release of 2',3'-dideoxycytidine, an inhibitor of HIV infectivity. 200
Structural determinants that make hexokinase susceptible to ubiquitin- and ATP-dependent proteolysis 199
Human red blood cells as bioreactors for the release of 2',3'-dideoxycytidine, an inhibitor of HIV infectivity 196
Genomic DNA in human blastocoele fluid 193
A new humanized antibody is effective against pathogenic fungi in vitro 193
Role and mechanism of hexokinase decay during reticulocyte maturation and cell aging 191
Monitoring erythropoietin abuse in athletes 190
Normalization of hyperglycemia in diabetic mice by enzyme-loaded erythrocytes 189
Expression, purification and preliminary crystallographic studies of human hexokinase I 189
In vivo accelerated acetaldehyde metabolism using acetaldehyde dehydrogenase-loaded erythrocytes 187
REVERSED-PHASE LIQUID CHROMATOGRAPHIC DETERMINATION OF 2’, 3’-DIDEOXYCYTIDINE IN HUMAN BLOOD SAMPLES 187
ALCUNE PROPRIETÀ DI GLOBULI ROSSI UMANI SOTTOPOSTI A DIALISI IPOTONICA E RISIGILLAMENTO DA UTILIZZARE COME VEICOLI O BIOREATTORI. 187
Modulation of ICAM-1 expression in ECV304 cells by macrophage-released cytokines 187
Erythrocyte-mediated delivery of drugs, peptides and modified oligonucleotides 186
Human hexokinase type I microheterogeneity is due to different amino-terminal 183
Molecular bases of hexokinase deficiency 182
Drug-loaded red blood cells for the control of the inflammatory response: selective targeting of nuclear factor-kB (NF-kB) 182
In vivo accelerated acetaldehyde metabolism using acetaldehyde dehydrogenase-loaded erythrocytes. 181
Expression of hexokinase mRNA in human hippocampus 177
Hexokinase mutations that produce nonspherocytic hemolytic anemia 177
Improved metabolic properties of hexokinase-overloaded human erythrocytes 173
Ubiquitin overexpression leads to stabilization of p53 and increased p21 (CIP1/WAF1) transcription by promoting E6AP autodegradation in HeLa cells 172
Modulation of NF-kB activation by targeted delivery of dexamethasone to macrophages 171
Improved stability of 2,3-bisphosphoglycerate during storage of hexokinase-overloaded erythrocytes 169
Ubiquitin over-expression promotes E6AP degradation and reactivation of the p53/mdm-2 pathway 168
Enzymatic properties of overexpressed human hexokinase fragments 167
Dynamic changes in immunoproteasome assembly and capping with regulatory particles in an invitro model of senescing macrophages 165
FKBP12-loaded erythrocytes as a potential delivery system for the immunosuppressant Tacrolimus 160
Patterns of immunoproteasome subunit expression and assembly into proteolytic particles in gastric cancer cells with different histotypes: implications for cancer metastasis 159
Localization and age-dependent expression of hexokinase mRNA in the rat brain 159
LOCKED NUCLEIC ACIDS (LNA): VERSATILE TOOLS FOR DESIGNING OLIGONUCLEOTIDE DECOYS WITH HIGH STABILITY AND AFFINITY 158
Role of hexokinase in the regulation of erythrocyte hexose monophosphate pathway under oxidative stress 158
Ubiquitin-dependent regulation of E6AP protein levels 156
Design of decoys oligonucleotides stabilized by Locked Nucleic Acids. 155
Extraction and reversed-phase high-performance liquid chromatographic determination of 2',3'-dideoxycytidine from human blood samples. 150
Induction of ubiquitin C (UBC) gene transcription is mediated by HSF1: role of proteotoxic and oxidative stress 149
Human red blood cell loading with hexokinase-inactivating antibodies. An in vitro model for enzyme deficiencies 148
Selective inhibition of NF-kB activation and TNF-alpha production in macrophages by red blood cell-mediated delivery of dexamethasone 147
Engineering new metabolic pathways in isolated cells for the degradation of guanidinoacetic acid and simultaneous production of creatine. 147
Development and in vitro characterization of a humanized scFv against fungal infections 145
UbC trascription is modulated by a mechanism that senses ubiquitin pool dynamics. 139
Different intron-mediated enhancement mechanisms for the 5'-UTR intron of the human UbC gene 138
Overexpression of ubiquitin downregulates transcription of the endogenous UbC gene in HeLa cells 138
Role of heat shock transcription factors in the induction of UbC gene expression in MG132-treated cells 134
Efficient inhibition of macrophage TNF-alpha production by red cell mediated drug targeting 129
MOLECULAR BASES OF NONSPHEROCYTIC HEMOLYTIC ANEMIA DUE TO HEXOKINASE MUTATIONS 128
Modulation of macrophage activation by red cell-mediated drug targeting 124
Extraction and reversed-phase high-performance liquid chromatographic determinaton of 2',3'-dideoxycytidine from human blood samples. 121
Engineered Red Blood Cells for the delivery and targeting of corticosteroid analogues 121
Molecular mechanism involved in glucocorticoid analogue action in Ataxia Telangiectasia: diferrentially expressed genes in AT cell lines in response to Dexamethasone 121
Red blood cell loading with hexokinase and hexokinase-inactivating antibodies. A new strategy for studying the role of enzymes in red cell metabolism and removal 120
Preclinical and clinical developments in enzyme-loaded red blood cells: an update 120
Transgene-derived wild-type and mutant ubiquitin affects both proteolysis and transcription in HeLa cells. 118
INCREASED GLUCOSE CONSUMPTION BY HUMAN AND MICE ERYTHROCYTES OVERLOADED WITH HEXOKINASE AND GLUCOSE OXIDASE. 116
Drug delivery system 115
Totale 20.960
Salva come PNG Salva come JPEG
Categoria #
all - tutte 72.761
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 72.761
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021108 0 0 0 0 0 0 0 0 0 0 0 108
2021/20221.087 80 97 119 152 36 44 49 60 91 71 29 259
2022/20231.688 198 90 28 179 164 341 1 153 311 71 97 55
2023/2024815 51 42 16 78 26 118 22 298 8 69 7 80
2024/20252.062 106 94 420 135 62 116 256 94 227 154 204 194
2025/20264.553 502 372 511 853 487 333 564 118 278 331 156 48
Totale 21.816